ICL Group Ltd. Files May 2024 Report on Form 6-K

TL;DR

ICL Group Ltd. just dropped its May 2024 6-K filing. Standard foreign private issuer report.

AI Summary

ICL Group Ltd. filed a Form 6-K on May 31, 2024, reporting on its activities for the month of May 2024. The company, formerly known as Israel Chemicals Ltd., is incorporated in Israel and has its principal executive offices in Tel Aviv. This filing is a report of a foreign private issuer under the Securities Exchange Act of 1934.

Why It Matters

This filing provides an update on ICL Group Ltd.'s ongoing operations and regulatory disclosures as a foreign private issuer, which is important for investors tracking the company's compliance and business activities.

Risk Assessment

Risk Level: low — This filing is a routine report of a foreign private issuer and does not contain specific financial results or significant corporate events that would typically indicate a higher risk.

Key Players & Entities

• ICL Group Ltd. (company) — Registrant
• Israel Chemicals Ltd. (company) — Former company name
• Tel Aviv (location) — Principal executive office location
• May 2024 (date) — Reporting period
• May 31, 2024 (date) — Filing date

FAQ

Key Financial Figures

• $7.5 billion — For the full year, we reported sales of $7.5 billion with adjusted EBITDA of $1.8 billion(1)
• $1.8 billion — of $7.5 billion with adjusted EBITDA of $1.8 billion(1). We also generated operating cash fl
• $1.6 billion — erated operating cash flow of more than $1.6 billion and $818 million of free cash flow, ref
• $818 million — cash flow of more than $1.6 billion and $818 million of free cash flow, reflecting our conti
• $0.55 — cashgeneration. For 2023, we delivered $0.55 of adjusted earnings per share and dist
• $0.27 — e and distributed an annual dividend of $0.27 per share, in accordance with our long-
• $1.7 billion — luded 2023 with fourth-quarter sales of $1.7 billion and adjusted EBITDA of $357 million. Al
• $357 million — of $1.7 billion and adjusted EBITDA of $357 million. Although sales experienced a year-over
• $10,015 — 23 US$M ex. Per share FY'22 FY'23 Sales $10,015 $7,536 Net income, attributable to the
• $7,536 — ex. Per share FY'22 FY'23 Sales $10,015 $7,536 Net income, attributable to the Company
• $2,159 — ributable to the Company's shareholders $2,159 $647 Adjusted net income, attributable
• $647 — le to the Company's shareholders $2,159 $647 Adjusted net income, attributable to th
• $2,350 — ributable to the Company's shareholders $2,350 $715 Diluted earnings per share $1.67 $
• $715 — le to the Company's shareholders $2,350 $715 Diluted earnings per share $1.67 $0.50
• $1.67 — $2,350 $715 Diluted earnings per share $1.67 $0.50 Adjusted diluted earnings per sha

Filing Documents

• zka2431534.htm (6-K) — 704KB
• exhibit_99-1.htm (EX-99.1) — 33KB
• a1.jpg (GRAPHIC) — 322KB
• a2.jpg (GRAPHIC) — 347KB
• image0.jpg (GRAPHIC) — 15KB
• img001_v2.jpg (GRAPHIC) — 6022KB
• img003_v2.jpg (GRAPHIC) — 4151KB
• img004_v2.jpg (GRAPHIC) — 3911KB
• img005_v2.jpg (GRAPHIC) — 3071KB
• img006_v2.jpg (GRAPHIC) — 2096KB
• img007_v2.jpg (GRAPHIC) — 2794KB
• img008_v2.jpg (GRAPHIC) — 3896KB
• img009_v2.jpg (GRAPHIC) — 2068KB
• img010_v2.jpg (GRAPHIC) — 2692KB
• img011_v2.jpg (GRAPHIC) — 3247KB
• img013_v2.jpg (GRAPHIC) — 4463KB
• img014_v2.jpg (GRAPHIC) — 3963KB
• img015_v2.jpg (GRAPHIC) — 4313KB
• img016_v2.jpg (GRAPHIC) — 3793KB
• img017_v2.jpg (GRAPHIC) — 2963KB
• img018_v2.jpg (GRAPHIC) — 4445KB
• img019_v2.jpg (GRAPHIC) — 2530KB
• img020_v2.jpg (GRAPHIC) — 3334KB
• img021_v2.jpg (GRAPHIC) — 3560KB
• img022_v2.jpg (GRAPHIC) — 3210KB
• img023_v2.jpg (GRAPHIC) — 907KB
• img024_v2.jpg (GRAPHIC) — 3559KB
• img025_v2.jpg (GRAPHIC) — 3854KB
• img026_v2.jpg (GRAPHIC) — 3065KB
• img027_v2.jpg (GRAPHIC) — 3901KB
• img028_v2.jpg (GRAPHIC) — 3034KB
• img029_v2.jpg (GRAPHIC) — 3075KB
• img030_v2.jpg (GRAPHIC) — 4408KB
• img031_v2.jpg (GRAPHIC) — 2395KB
• img032_v2.jpg (GRAPHIC) — 1913KB
• img033_v2.jpg (GRAPHIC) — 1855KB
• img034_v2.jpg (GRAPHIC) — 3868KB
• img035_v2.jpg (GRAPHIC) — 4068KB
• img036_v2.jpg (GRAPHIC) — 2582KB
• img037_v2.jpg (GRAPHIC) — 4694KB
• img038_v2.jpg (GRAPHIC) — 3258KB
• img039_v2.jpg (GRAPHIC) — 2202KB
• img040_v2.jpg (GRAPHIC) — 1992KB
• img041_v2.jpg (GRAPHIC) — 135KB
• 0001178913-24-001913.txt ( ) — 174232KB

From the Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File Number: 001-13742 ICL GROUP LTD. (Exact name of registrant as specified in its charter) ICL Group Ltd. Millennium Tower 23 Aranha Street P.O. Box 20245 Tel Aviv, 61202 Israel (972-3) 684-4400 (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: Form 20-F Form 40-F ICL GROUP LTD. INCORPORATION BY REFERENCE This report on Form 6-K shall be deemed to be incorporated by reference into the registration statement on Form S-8 (Registration Number: 333-205518) of ICL Group Ltd. and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished. In addition, this report on Form 6-K shall be deemed to be incorporated by reference into the Israeli Shelf Prospectus of ICL Group Ltd. filed with the Israel Securities Authority and dated February 28, 2022 (Filing Number: 2022-02-019821) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished. ICL GROUP LTD. 1. Notice of Annual Meeting of Shareholders and Proxy Statement, dated July 17, 2024 I C L Gr o u p Lt d . May 31, 2024 NOTICE OF 2024 ANNUAL GENERAL MEETING OF SHAREHOLDERS Impact for a sustainable future www .icl-gr oup.com DEAR SHAREHOLDER, You are cordially invited to attend ICL Group Ltd.'s ("ICL") 2024 Annual General Meeting to be held on Wednesday, July 17, 2024, at 10:00 a.m. (Israel time). The notice of the meeting, as well as items of business and voting instructions, are included in this document. I would like to take this opportunity and provide an update on the recent developments at ICL and the broader context in which we operate. The past few months have presented us with a unique set of challenges, particularly in the fourth quarter, due to the war in Israel. Despite these adversities, I am pleased to report that our efforts to minimize disruption and maintain production levels have been successful. Additionally, the majority of our employees who had been called up for military reserve service, have now resumed their full-time roles at ICL. Despite these external factors, we were able to effectively manage those areas within our control, while swiftly reacting to a changing external environment throughout 2023. Our team did an excellent job managing our supply chain amidst war, political tensions and market volatility. We also continued to gain efficiencies and drive down costs across the business. As a result, we were able to deliver a solid performance in 2023, following a record year in 2022. For the full year, we reported sales of $7.5 billion with adjusted EBITDA of $1.8 billion(1). We also generated operating cash flow of more than $1.6 billion and $818 million of free cash flow, reflecting our continued focus on cashgeneration. For 2023, we delivered $0.55 of adjusted earnings per share and distributed an annual dividend of $0.27 per share, in accordance with our long-standing policy to pay out up to 50% of adjusted net income to our shareholders. Our efficiency and cost savings initiatives, which we put in place early in 2023, delivered ahead of plan. While we made some tough decisions to better position ourselves for the future, we also maintained our focus on expanding our strategic partnerships. As a result, we gained market share across some of our key specialtiesbusinesses. We also expanded into additional new end-markets, with the groundbreaking of new advanced facilities and the launch of new innovative products, which will have a long-term impact on growth. In conclusion, I would like to express my sincere gratitude for your continued support during these difficult times. I am confident that ICL will navigate these challenges and continue to build on its success. Sincerely yours, Raviv Zoller CEO and President (1) Non-IFRS financials measures and reconciliation to IFRS measures are described in the accompanying proxy statement for the ICL 2024 Annual General Meeting and Appendix A thereto. 5 2/41 ITEMS OF BUSINESS The following items of business will be covered, as more fully described in the accompanying proxy statement: 1. Re-election of Yoav Doppelt, Aviad Kaufman, Avisar Paz, Sagi Kabla, Reem Aminoach, Lior Reitblatt, Tzipi Ozer Armon, Gadi Lesin, Michal Silverberg and Shalom Shlomo to serve as directors, effective NOTICE OF MEETING The 2024 Annual GeneralMeeting of Shareholders (the "Meeting") of ICL Group Ltd.(the "Company") will be held: as of the date of the Meeting, until the next annual general meeting of At the offices of the Company, Millennium shareholders of the Company or unti

View Full Filing

View this 6-K filing on SEC EDGAR